TABLE 2.
The baseline data for patients with lower and higher ST6GAL1
| Characters | Mean ± SD or n (%) | P | |
|---|---|---|---|
|
Lower ST6GAL1 (≤5825 pg/mL) |
Higher ST6GAL1 (>5825 pg/mL) |
||
| Gender (M/F) | 30 (60)/20 (40) | 25 (50)/25 (50) | .32 |
| Age (mean ± SD, y) | 40.1 ± 12.1 | 38.6 ± 13.5 | .56 |
| Serum creatinine (μmol/L) | 69.22 ± 49.08 | 70.10 ± 52.06 | .93 |
| eGFR (mL/min/1.73 m2) | 86.19 ± 30.77 | 88.73 ± 27.14 | .67 |
| Uric acid (μmol/L) | 387.88 ± 126.00 | 364.76 ± 104.12 | .32 |
| Bb (μg/mL) | 3.60 ± 0.49 | 5.21 ± 2.19 | ＜.01 |
| C3a (ng/mL) | 363.24 ± 266.61 | 3240.84 ± 3870.66 | ＜.01 |
| C4d (μg/mL) | 4.73 ± 1.34 | 10.27 ± 7.20 | ＜.01 |
| C5b‐9 (ng/mL) | 450.39 ± 52.49 | 877.76 ± 502.32 | ＜.01 |
| Serum IgA (mg/dL) | 317.91 ± 142.00 | 352.65 ± 123.20 | .05 |
| Serum IgG (mg/dL) | 1060.50 ± 246.12 | 1124.16 ± 293.52 | .28 |
| Serum IgM (mg/dL) | 117.53 ± 62.89 | 117.78 ± 57.19 | .98 |
| Serum C3 (mg/dL) | 89.03 ± 16.15 | 92.47 ± 19.11 | .38 |
| Serum C4 (mg/dL) | 22.86 ± 6.79 | 23.56 ± 5.92 | .61 |
| Proteinuria (mg/24 h) | 1595.44 ± 1571.92 | 1926.70 ± 1642.67 | .06 |
| Urine RBC (/HP) | 65.42 ± 149.78 | 75.91 ± 265.32 | .81 |
| Oxford classification | |||
| M score (M0/M1) | 4 (8)/46 (92) | 3 (6)/47 (94) | .70 |
| E score (E0/E1) | 24 (48)/26 (52) | 23 (46)/27 (54) | .84 |
| S score (S0/S1) | 26 (52)/24 (48) | 34 (68)/16 (32) | .10 |
| T score (T0/T1/T2) | 21 (42)/24 (48)/5 (10) | 23 (46)/22 (44)/5 (10) | .92 |
| C score (C0/C1/C2) | 8 (16)/30 (60)/12 (24) | 14 (28)/32 (64)/4 (8) | .05 |